Patents by Inventor Joseph Lambing

Joseph Lambing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230158027
    Abstract: Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein.
    Type: Application
    Filed: November 10, 2020
    Publication date: May 25, 2023
    Inventors: Timothy Carlson, Carlos L. Del Rio, Jay M. Edelberg, Sarah Fernandes, Marcus Patrick Henze, Yanfei Ma, Robert McDowell, Matthew Edwards Mealiffe, Amy Sehnert, Marc J. Semigran, Kathy L. Lampl, David Zhang, Milind Y. Desai, Steve E. Nissen, Liang Fang, Joseph Lambing, Wanying Li, Danielle L. Aubele, Brian Edmund Kane, Louis Charles Sehl
  • Publication number: 20220313695
    Abstract: Provided are methods for treating hypertrophic cardiomyopathy and diastolic dysfunction.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Inventors: Marc J. Semigran, June H. Lee, Joseph Lambing, Eric Green, Marc Evanchik, Timothy Carlson, David Zhang
  • Publication number: 20220226324
    Abstract: Provided are methods for treating hypertrophic cardiomyopathy and diastolic dysfunction.
    Type: Application
    Filed: March 23, 2022
    Publication date: July 21, 2022
    Inventors: Marc J. Semigran, June H. Lee, Joseph Lambing, Eric Green, Marc Evanchik, Timothy Carlson, David Zhang
  • Publication number: 20200054636
    Abstract: Provided are methods for treating hypertrophic cardiomyopathy and diastolic dysfunction.
    Type: Application
    Filed: March 26, 2019
    Publication date: February 20, 2020
    Inventors: Marc J. Semigran, June H. Lee, Joseph Lambing, Eric Green, Marc Evanchik
  • Publication number: 20110160250
    Abstract: The present invention provides crystalline forms of a mesylate salt of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide and pharmaceutical compositions and methods thereof.
    Type: Application
    Filed: December 16, 2010
    Publication date: June 30, 2011
    Inventors: Anjali Pandey, Juan Wang, Joseph Lambing